EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)

Bridging Community Mental Health and Primary Care to Improve Medication Monitoring and Outcomes for Patients With Mental Illness Taking Second-Generation Antipsychotics—Phase 2

Mark E Schneiderhan, Carolyn O'Donnell, Sarah K Jackson, Danielle A MacDonald, Ann M Yapel, Colleen M Renier, Jennifer Nelson Albee, Keri D Hager

The Primary Care Companion For CNS Disorders · 27.06.2023 · 25 (3)

DOI: 10.4088/pcc.22m03432 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift The Primary Care Companion For CNS Disorders, online erschienen am 27.06.2023. Verfasst von Mark E Schneiderhan und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of Minnesota College of Pharmacy, Department of Pharmacy Practice and Pharmaceutical Sciences, Duluth, Minnesota. Hauptthemen laut MEDLINE: Antipsychotic Agents, Mental Disorders. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsMental DisordersHumansQuality ImprovementMental HealthPrimary Health CareLipids

Substanzen

Antipsychotic AgentsLipids

Autor:innen und Institutionen

  • University of Minnesota College of Pharmacy, Department of Pharmacy Practice and Pharmaceutical Sciences, Duluth, Minnesota.
  • Human Development Center, Department of Psychiatry, Duluth, Minnesota.
  • Mark E. Schneiderhan, PharmD, BCPP, University of Minnesota-Duluth, Department of Pharmacy Practice and Pharmaceutical Sciences, 232 Life Science 1110 Kirby Drive, Duluth, Minnesota 55812-3003 (meschnei@d.umn.edu).
  • Edward Hines Jr, Veterans Administration Hospital, Hines, Illinois.
  • Essentia Institute of Rural Health, Essentia Health, Duluth, Minnesota.
  • Essentia Health, Behavioral Health, Duluth, Minnesota.

Zitieren

APA

Schneiderhan, M. E., O'Donnell, C., Jackson, S. K., MacDonald, D. A., Yapel, A. M., Renier, C. M., Albee, J. N., & Hager, K. D. (2023). Bridging Community Mental Health and Primary Care to Improve Medication Monitoring and Outcomes for Patients With Mental Illness Taking Second-Generation Antipsychotics—Phase 2. The Primary Care Companion For CNS Disorders, 25(3). https://doi.org/10.4088/pcc.22m03432

Vancouver

Schneiderhan ME, O'Donnell C, Jackson SK, MacDonald DA, Yapel AM, Renier CM, et al. Bridging Community Mental Health and Primary Care to Improve Medication Monitoring and Outcomes for Patients With Mental Illness Taking Second-Generation Antipsychotics—Phase 2. The Primary Care Companion For CNS Disorders. 2023;25(3). doi:10.4088/pcc.22m03432

BibTeX
@article{Schneiderhan2023,
  author = {Schneiderhan, Mark E and O'Donnell, Carolyn and Jackson, Sarah K and MacDonald, Danielle A and Yapel, Ann M and Renier, Colleen M and Albee, Jennifer Nelson and Hager, Keri D},
  title = {Bridging Community Mental Health and Primary Care to Improve Medication Monitoring and Outcomes for Patients With Mental Illness Taking Second-Generation Antipsychotics—Phase 2},
  journal = {The Primary Care Companion For CNS Disorders},
  year = {2023},
  volume = {25},
  number = {3},
  doi = {10.4088/pcc.22m03432}
}
Kostenlos starten →